June 2020
Volume 61, Issue 7
Free
ARVO Annual Meeting Abstract  |   June 2020
Neuroprotective Mechanisms of Dark Rearing on cGMP in rd10 mice
Author Affiliations & Notes
  • Paul Yang
    Ophthalmology, Casey Eye Inst, Oregon Hlth & Science Univ, Portland, Oregon, United States
  • Hope Titus
    Ophthalmology, Casey Eye Inst, Oregon Hlth & Science Univ, Portland, Oregon, United States
  • Jordan Hiblar
    Ophthalmology, Casey Eye Inst, Oregon Hlth & Science Univ, Portland, Oregon, United States
  • Dahlia Wafai
    Ophthalmology, Casey Eye Inst, Oregon Hlth & Science Univ, Portland, Oregon, United States
  • Robert M Duvoisin
    Chemical Physiology and Biochemistry, Oregon Health and Science University, Portland, Oregon, United States
  • Richard G Weleber
    Ophthalmology, Casey Eye Inst, Oregon Hlth & Science Univ, Portland, Oregon, United States
  • Catherine W Morgans
    Chemical Physiology and Biochemistry, Oregon Health and Science University, Portland, Oregon, United States
  • Mark E Pennesi
    Ophthalmology, Casey Eye Inst, Oregon Hlth & Science Univ, Portland, Oregon, United States
  • Footnotes
    Commercial Relationships   Paul Yang, AGTC (C); Hope Titus, None; Jordan Hiblar, None; Dahlia Wafai, None; Robert Duvoisin, None; Richard Weleber, None; Catherine Morgans, None; Mark Pennesi, None
  • Footnotes
    Support  -Collins Medical Trust -Medical Research Foundation New Investigator Grant -NIH K08EY026650 (PY) -Foundation Fighting Blindness Career Development Award CD-NMT-0714-0648 (PY) -“Supported by grant P30 EY010572 from the National Institutes of Health (Bethesda, MD), and by unrestricted departmental funding from Research to Prevent Blindness (New York, NY).”
Investigative Ophthalmology & Visual Science June 2020, Vol.61, 2482. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Paul Yang, Hope Titus, Jordan Hiblar, Dahlia Wafai, Robert M Duvoisin, Richard G Weleber, Catherine W Morgans, Mark E Pennesi; Neuroprotective Mechanisms of Dark Rearing on cGMP in rd10 mice. Invest. Ophthalmol. Vis. Sci. 2020;61(7):2482.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : Dark-rearing (DR) rd10 mice has long been known to be neuroprotective, albeit poorly understood. We previously showed that DR slows the rate of retinal degeneration as expected, does not change whole retinal PDE6B expression levels, is associated with stronger mislocalized anti-PDE6B staining in the inner segments, and predominantly preserves rod photoreceptor function, but not cone receptor function. We hypothesize that DR-associated neuroprotection also fundamentally alters cGMP associated photoreceptor cytotoxicity.

Methods : Rd10 mice were DR from birth and compared to c57 and rd10 mice that were RR (12 hr light/12 hr dark cycle) from birth. At P15, 20, 27, and 35, whole retina homogenates were collected for cGMP mass spectrometry, and eye cups were harvested for cGMP IHC. ANOVA and Sidak were used for statistical analysis.

Results : For whole retinal cGMP, rd10 mice that were DR tended to have greater levels than RR rd10 mice at P15 and P27, with significance at P35 (5.16 ±0.84 vs. 3.12 ±0.55, p =0.026). For cGMP IHC, DR rd10 mice had significantly greater cGMP immunostaining of the photoreceptors than RR rd10 mice at P15 (1.73 ±0.40 vs 0.19 ±0.05, p=0.0361), but significantly lower cGMP staining than RR rd10 mice at P27 (2.27 ±0.37 vs 12.35 ±0.91, p<0.0001) and P35 (0.05 ±0.02 vs 6.14 ±0.59, p<0.0001). At P35, there was no difference in the negligible amount of cGMP immunostaining between c57 mice and rd10 DR mice (p>0.9999).

Conclusions : The neuroprotective mechanisms of DR in rd10 has opposing effects of increasing whole retinal cGMP levels, but reducing cGMP IHC immunostaining of the photoreceptors. These results suggest that cGMP-dependent photoreceptor pathophysiology is complex, and whole retinal cGMP levels and cGMP IHC immunostaining may be quantifying distinct processes associated with cGMP cytotoxicity.

This is a 2020 ARVO Annual Meeting abstract.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×